A Review of Probiotic Ingredient Safety Supporting Monograph Development Conducted by the United States Pharmacopeia (USP)

References

• Aguirre M, Collins MD. 1993. Lactic acid bacteria and human clinical infection. J Appl Bacteriol. 75(2):95–107. doi:10.1111/j.1365-2672.1993.tb02753.x.
   PubMedGoogle Scholar
• Aljuobori A, Abdullah N, Zulkifli I, Soleimani A, Liang J, Oskoueian E. 2014. Lactobacillus salivarius fermentation reduced glucosinolate and fibre in canola meal. JFR. 3(5):95. doi:10.5539/jfr.v3n5p95.
   Google Scholar
• Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor M, Garaiova I, Plummer SF, Wang D, Morgan G. 2010. Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J Nutr. 140(3):483–488. doi:10.3945/jn.109.117093.
   PubMed Web of Science ®Google Scholar
• Banerjee C, Bustamante CI, Wharton R, Talley E, Wade JC. 1988. Bacillus infections in patients with cancer. Arch Intern Med. 148(8):1769–1774. doi:10.1001/archinte.1988.00380080059017.
   PubMedGoogle Scholar
• Barnard JP, Stinson MW. 1996. The alpha-hemolysin of Streptococcus gordonii is hydrogen peroxide. Infect Immun. 64(9):3853–3857. doi:10.1128/iai.64.9.3853-3857.1996.
   PubMed Web of Science ®Google Scholar
• Barreto FM, Simão ANC, Morimoto HK, Lozovoy MAB, Dichi I, Miglioranza LHS. 2014. Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome. Nutrition. 30(7-8):939–942. doi:10.1016/j.nut.2013.12.004.
   PubMed Web of Science ®Google Scholar
• Bernardeau M, Guguen M, Vernoux JP. 2006. Beneficial lactobacilli in food and feed: long-term use, biodiversity and proposals for specific and realistic safety assessments. FEMS Microbiol Rev. 30(4):487–513. doi:10.1111/j.1574-6976.2006.00020.x.
   PubMed Web of Science ®Google Scholar
• Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V. 2003. Safety of probiotics that contain Lactobacilli or Bifidobacteria. Clin Infect Dis. 36(6):775–780. doi:10.1086/368080.
   PubMed Web of Science ®Google Scholar
• Brettin T, Davis JJ, Disz T, Edwards RA, Gerdes S, Olsen GJ, Olson R, Overbeek R, Parrello B, Pusch GD, et al. 2015. RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci Rep. 5(1):8365. doi:10.1038/srep08365.
   PubMed Web of Science ®Google Scholar
• Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR. 2006. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol. 72(4):3050–3053. doi:10.1128/AEM.72.4.3050-3053.2006.
   PubMed Web of Science ®Google Scholar
• Burton JP, Cowley S, Simon RR, McKinney J, Wescombe PA, Tagg JR. 2011. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol. 49(9):2356–2364. doi:10.1016/j.fct.2011.06.038.
   PubMed Web of Science ®Google Scholar
• Cabana MD, McKean M, Caughey AB, Fong L, Lynch S, Wong A, Leong R, Boushey HA, Hilton JF. 2017. Early probiotic supplementation for eczema and asthma prevention: a randomized controlled trial. Pediatrics. 140(3):e20163000. doi:10.1542/peds.2016-3000.
   Web of Science ®Google Scholar
• Chaves BD, Brashears MM, Nightingale KK. 2017. Applications and safety considerations of Lactobacillus salivarius as a probiotic in animal and human health. J Appl Microbiol. 123(1):18–28. doi:10.1111/jam.13438.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Vizzaccaro A, Cirillo I, Tosca MA. 2005. Bacillus clausii exerts immuno-modulatory activity in allergic subjects: a pilot study. Eur Ann Allergy Clin Immunol. 37(4):129–134.
   PubMedGoogle Scholar
• Clausen PT, Aarestrup FM, Lund O. 2018. Rapid and precise alignment of raw reads against redundant databases with KMA. BMC Bioinformatics. 19(1):307. doi:10.1186/s12859-018-2336-6.
   PubMed Web of Science ®Google Scholar
• Costa GN, Marcelino-Guimarães FC, Vilas-Bôas GT, Matsuo T, Miglioranza LHS. 2014. Potential fate of ingested Lactobacillus plantarum and its occurrence in human feces. Appl Environ Microbiol. 80(3):1013–1019. doi:10.1128/AEM.02588-13.
   PubMed Web of Science ®Google Scholar
• Coulin P, Farah Z, Assanvo J, Spillmann H, Puhan Z. 2006. Characterisation of the microflora of attiéké, a fermented cassava product, during traditional small-scale preparation. Int J Food Microbiol. 106(2):131–136. doi:10.1016/j.ijfoodmicro.2005.06.012.
   PubMed Web of Science ®Google Scholar
• Cuentas AM, Deaton J, Khan S, Davidson J, Ardita C. 2017. The effect of Bacillus subtilis DE111 on the daily bowel movement profile for people with occasional gastrointestinal irregularity. J Probiotics Health. 5(4):04. doi:10.4172/2329-8901.1000189.
   Google Scholar
• Davis JJ, Wattam AR, Aziz RK, Brettin T, Butler R, Butler RM, Chlenski P, Conrad N, Dickerman A, Dietrich E, et al. 2020. The PATRIC Bioinformatics Resource Center: expanding data and analysis capabilities. Nucleic Acids Res. 48(D1):D606–D612. doi:10.1093/nar/gkz943.
   PubMed Web of Science ®Google Scholar
• Delorme C. 2008. Safety assessment of dairy microorganisms: Streptococcus thermophilus. Int J Food Microbiol. 126(3):274–277. doi:10.1016/j.ijfoodmicro.2007.08.014.
   PubMed Web of Science ®Google Scholar
• Dickerson F, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C, Schweinfurth L, Stallings C, Sweeney K, Goga J, et al. 2018. Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: A randomized controlled trial. Bipolar Disord. 20(7):614–621. doi:10.1111/bdi.12652.
   PubMed Web of Science ®Google Scholar
• Di Pierro F, Colombo M, Zanvit A, Rottoli AS. 2016. Positive clinical outcomes derived from using Streptococcus salivarius K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation. DHPS. ume 8:77–81. doi:10.1016/j.fct.2011.06.038.
   Google Scholar
• Duc LH, Hong HA, Barbosa TM, Henriques AO, Cutting SM. 2004. Characterization of Bacillus Probiotics Available for Human Use. Appl Environ Microbiol. 70(4):2161–2171. doi:10.1128/aem.70.4.2161-2171.2004.
   PubMed Web of Science ®Google Scholar
• EFSA. 2007. Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. doi:10.2903/j.efsa.2007.587. (Accessed 10 November 2023).
   Google Scholar
• EFSA. 2012. Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. Efsa J. 10(6):2740.
   Google Scholar
• EFSA. 2018. Guidance on the characterisation of microorganisms used as feed additives or as production organisms. Efsa J. 16(3):5206. doi:10.2903/j.efsa.2018.5206.
   Web of Science ®Google Scholar
• EFSA. 2020a. Scientific Opinion on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA (2017-2019.)Efsa J. 18(2):5966. doi:10.2903/j.efsa.2020.5966.
   Web of Science ®Google Scholar
• EFSA. 2020b. Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 13: suitability of taxonomic units notified to EFSA until September 2020. Efsa J. 19(1):6377. doi:10.2903/j.efsa.2021.6377.
   Web of Science ®Google Scholar
• EFSA. 2021. Qualified presumption of safety (QPS). European food safety authority (EFSA). Available at: https://www.efsa.europa.eu/en/topics/topic/qualified-presumption-safety-qps. (Accessed 10 November 2023).
   Google Scholar
• FAO/WHO. 2001. Report of a Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including poder milk with live lactic acid bacteria. https://www.fao.org/3/ao512e/a0512e.pdf. (Accessed 10 November 2023).
   Google Scholar
• FDA, GRN No. 231. 2008. Lactobacillus casei subsp. rhamnosus strain GG. Mead Johnson & Company. Date of closure May 29, 2008. https://www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices&id=231&sort=GRN_No&order=DESC&startrow=1&type=basic&search=231. Accessed 15 November 2023.
   Google Scholar
• FDA, GRN No. 254. 2008. Lactobacillus reuteri strain DSM 17938. BioGaia AB. Date of closure November 18, 2008. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjFq4OdmP2CAxW-m2oFHUGJBHkQFnoECBkQAQ&url=https%3A//downloads.regulations.gov/FDA-2021-S-0023-0004/content.pdf&usg=AOvVaw2r7VmeT5CxbIkvPIYYk77u&opi=89978449.
   Google Scholar
• FDA, GRN No 288. 2009. Lactobacillus rhamnosus strain HN001 GRAS Notice 288, Lactobacillus rhamnosus strain HN001 (fda.gov). Accessed 20 November 2023
   Google Scholar
• FDA, GRN No 865. 2010. Lactobacillus acidophilus NCFM ®. GRAS Noice 865, Lactobacillus acidophilus NCFM (fda.gov). Accessed 15 November 2023.
   Google Scholar
• FDA, GRN No 357. 2011. Lactobacillus acidophilus NCFM GRAS Notice 357, Inactivated Lactobacillus acidophilus NCFM (fda.gov). Accessed 20 November 2023
   Google Scholar
• FDA, GRN No. 429. 2012. Lactobacillus casei strain Shirota. Yakult Honsha Co., Ltd. Date of closure April 10, 2012. www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices&id=429&sort=GRN_No&order=DESC&startrow=1&type=basic&search=Lactobacillus%20casei. Accessed 14 November 2023.
   Google Scholar
• FDA, GRN No 445. 2013. Bifidobacterium animalis subsp. lactis strains HN019, Bi-07, Bl-04 and B420 GRAS Notice 445, Bifidobacterium animalis subsp. lactis strains HN019, Bi-07, Bl-04 and B420 (fda.gov). Accessed 20 November 2023
   Google Scholar
• FDA, GRN No 502. 2014. Lactobacillus acidophilus La-14 GRAS Notice 502, Lactobacillus acidophilus La-14 (fda.gov). Accessed 20 November 2023
   Google Scholar
• FDA, GRN No 526. 2015. Bacillus coagulans strain Unique IS2 spores preparation GRAS Notice 526, Bacillus coagulans strain Unique IS2 spores preparation (fda.gov). Accessed 20 November 2023
   Google Scholar
• FDA, GRN No. 591. 2015. GRAS Exemption Claim for Streptococcus salivarius K12. http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/default.htm. Accessed 15 November 2023.
   Google Scholar
• FDA, GRN No. 601. 2015. Bacillus coagulans SBC37-01 spore preparation. Sabinsa Corporation. Date of closure April 28, 2016. https://www.cfsanappsexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=601&sort=GRN_No&order=DESC&startrow=1&type=basic&search=Bacillus. Accessed 13 November 2023.
   Google Scholar
• FDA, GRN No. 722. 2018. Lactobacillus plantarum Lp-115. Dupont Nutrition & Health. Date of closure on February 16, 2018. https://www.cfsanappsexternal.fda.gov/scripts/fdcc/?set=GRASNotices&id=722&sort=GRN_No&order=DESC&startrow=1&type=basic&search=LACTOBACILLUS%20PLANTARUM. Accessed 14 November 2023.
   Google Scholar
• FDA, GRN No. 807. 2019. Streptococcus salivarius M18. BLIS Technologies Ltd. Date of closure June 9, 2019 https://www.cfsanappsexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=807&sort=GRN_No&order=DESC&startrow=1&type=basic&search=Streptococcus%20salivarius. Accessed 13 November 2023.
   Google Scholar
• FDA, GRN No. 831. 2019. FDA has no questions GRAS Notice GRN 831 Agency Response Letter - Bacillus subtilis DE111 (fda.gov). Accessed 15 November 2023.
   Google Scholar
• Forsberg KJ, Patel S, Gibson MK, Lauber CL, Knight R, Fierer N, Dantas G. 2014. Bacterial phylogeny structures soil resistomes across habitats. Nature. 509(7502):612–616. doi:10.1038/nature13377.
   PubMed Web of Science ®Google Scholar
• Freedman KE, Hill JL, Wei Y, Vazquez AR, Grubb DS, Trotter RE, Wrigley SD, Johnson SA, Foster MT, Weir TL. 2021. Examining the gastrointestinal and immunomodulatory effects of the novel probiotic Bacillus subtilis DE111. IJMS. 22(5):2453. doi:10.3390/ijms22052453.
   Google Scholar
• Gebert S, Davis E, Rehberger T, Maxwell CV. 2011. Lactobacillus brevis strain 1E1 administered to piglets through milk supplementation prior to weaning maintains intestinal integrity after the weaning event. Benef Microbes. 2(1):35–45. doi:10.3920/bm2010.0043.
   PubMed Web of Science ®Google Scholar
• Giske CG, Turnidge J, Cantón R, Kahlmeter G, EUCAST Steering Committee. 2021. Update From The European Committee On Antimicrobial Suseptibility Testing (EUCAST). J Clin Microbiol. 60(3):e0027621. doi:10.1128/jcm.00276-21.
   PubMed Web of Science ®Google Scholar
• Gøbel RJ, Larsen N, Jakobsen M, Mølgaard C, Michaelsen KF. 2012. Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome. J Pediatr Gastroenterol Nutr. 55(6):673–678. doi:10.1097/mpg.0b013e318263066c.
   PubMed Web of Science ®Google Scholar
• Gomes AC, de Sousa RG, Botelho PB, Gomes TL, Prada PO, Mota JF. 2017. The additional effects of a probiotic mix on abdominal adiposity and antioxidant Status: A double-blind, randomized trial. Obesity (Silver Spring). 25(1):30–38. doi:10.1002/oby.21671.
   PubMed Web of Science ®Google Scholar
• Gueimonde M, Sánchez B, G de Los Reyes-Gavilán C, Margolles A. 2013. Antibiotic resistance in probiotic bacteria. Front Microbiol. 4:202. doi:10.3389/fmicb.2013.00202.
   PubMed Web of Science ®Google Scholar
• Gupta RS, Patel S, Saini N, Chen S. 2020. Robust demarcation of 17 distinct Bacillus species clades, proposed as novel Bacillaceae genera, by phylogenomics and comparative genomic analyses: description of Robertmurraya kyonggiensis sp. nov. and proposal for an emended genus Bacillus limiting it only to the members of the Subtilis and Cereus clades of species. Int J Syst Evol Microbiol. 70(11):5753–5798. doi:10.1099/ijsem.0.004475.
   PubMed Web of Science ®Google Scholar
• Harnett J, Davey G, Patrick A, Caddick C, Pearce L. 2011. Lactic Acid Bacteria | Streptococcus thermophilus. In: Fuquay JW, ed. Encyclopedia of Dairy Sciences (Second Edition). San Diego: Academic Press, p. 143–148.
   Google Scholar
• Health Canada. 2022. Probiotics monograph available at http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=probio&lang=eng. Accessed 15 November 2023.
   Google Scholar
• Health Canada. 2023. Monograph on Probiotics. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=probio&lang=eng. Accessed 31 October 2023.
   Google Scholar
• Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. 2014. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 11(8):506–514. doi:10.1038/nrgastro.2014.66.
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Evans SJ, Gotzsche PC, O’Neill RT, Altman DG, Schulz K, Moher D, Group C, CONSORT Group. 2004. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 141(10):781–788. doi:10.7326/0003-4819-141-10-200411160-00009.
   PubMed Web of Science ®Google Scholar
• Jackson SA, Schoeni JL, Vegge C, Pane M, Stahl B, Bradley M, Goldman VS, Burguière P, Atwater JB, Sanders ME. 2019. Improving end-user trust in the quality of commercial probiotic products. Front Microbiol. 10:739. doi:10.3389/fmicb.2019.00739.
   PubMed Web of Science ®Google Scholar
• N J, Sudha M R. 2015. Bacillus clausii-The Probiotic of Choice in the Treatment of Diarrhoea. J Yoga Phys Ther. 05(04):1. doi:10.4172/2157-7595.1000211.
   Google Scholar
• Kim KH, Jeong CH, Joo SJ, Park JH, Moon JY, Cho EJ, Lee HT, Kwon HJ, Kim BW, Eom SH, et al. 2015. Single Dose Oral Toxicity of Bacillus subtilis JNS in ICR Mice. Journal of the Korean Society of Food Science and Nutrition. 44(1):24–28. doi:10.3746/jkfn.2015.44.1.024.
   Google Scholar
• Labellarte G, Maher M. 2019. Tolerance and effect of a probiotic supplement delivered in capsule form. Food and Nutrition Sciences. 10(06):626. doi:10.3390/sports6030070.
   Google Scholar
• Lakshmi SG, Jayanthi N, Saravanan M, Ratna MS. 2017. Safety assesment of Bacillus clausii UBBC07, a spore forming probiotic. Toxicol Rep,. 4:62–71. doi:10.1016/j.toxrep.2019.06.004.
   PubMedGoogle Scholar
• Larsen N, Vogensen FK, Gøbel RJ, Michaelsen KF, Forssten SD, Lahtinen SJ, Jakobsen M. 2013. Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin Nutr. 32(6):935–940. doi:10.1016/j.clnu.2013.02.007.
   PubMed Web of Science ®Google Scholar
• Lefevre M, Racedo SM, Ripert G, Housez B, Cazaubiel M, Maudet C, Jüsten P, Marteau P, Urdaci MC. 2015. Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immun Ageing. 12(1):24. doi:10.1186/s12979-015-0051-y.
   PubMedGoogle Scholar
• Madempudi RS, Neelamraju J, Ahire JJ, Gupta SK, Shukla VK. 2020. Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study. Probiotics Antimicrob Proteins. 12(2):335–342. doi:10.1007/s12602-019-09542-9.
   PubMed Web of Science ®Google Scholar
• Mattarelli P, Bonaparte C, Pot B, Biavati B. 2008. Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. suis comb. nov. Int J Syst Evol Microbiol. 58(Pt 4):767–772. doi:10.1099/ijs.0.65319-0.
   PubMedGoogle Scholar
• MarketsandMarkets. 2021. Probiotics Market by Applications (Functional Food & Beverages (Dairy Products, Non-dairy Beverages, Infant Formula, Cereals), Dietary Supplements, Feed), Ingredient (Bacteria, Yeast), Form (Dry, Liquid), End User, and Region – Global Forecast to 2026. Probiotics Market Growth Analysis, Trends, and Forecasts to 2026 | MarketsandMarkets. (Accessed 21 January 2022).
   Google Scholar
• Merenstein D, Pot B, Leyer G, Ouwehand AC, Preidis GA, Elkins CA, Hill C, Lewis ZT, Shane AL, Zmora N, et al. 2023. Emerging issues in probiotic safety: 2023 perspectives. Gut Microbes. 15(1):2185034. doi:10.1080/19490976.2023.2185034.
   PubMed Web of Science ®Google Scholar
• Oketch-Rabah HA, Roe AL, Muldoon-Jacobs K, Giancaspro GI. 2018. Challenges and opportunities for improving the safety assessment of botanical dietary supplements: A United States Pharmacopeia perspective. Clin Pharmacol Ther. 104(3):426–429. doi:10.1002/cpt.1113.
   PubMed Web of Science ®Google Scholar
• Ouwehand AC, Forssten S, Hibberd AA, Lyra A, Stahl B. 2016. Probiotic approach to prevent antibiotic resistance. Ann Med. 48(4):246–255. doi:10.3109/07853890.2016.1161232.
   PubMed Web of Science ®Google Scholar
• Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, Simoneau G, Bergmann JF, Brassart D, Bornet F, Ouwehand AC. 2008. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol. 53(1):107–113. doi:10.1111/j.1574-695x.2008.00413.x.
   PubMedGoogle Scholar
• Piatek J, Sommermeyer H, Bernatek M, Ciechelska-Rybarczyk A, Oleskow B, Sommer Mikkelsen L, Bundvig Barken K. 2019. Persistent infection by Salmonella enterica servovar Typhimurium: are synbiotics a therapeutic option? - a case report. Benef Microbes. 10(2):211–217. doi:10.3920/bm2018.0080.
   PubMed Web of Science ®Google Scholar
• Pradhan D, Mallappa RH, Grover S. 2020. Comprehensive Approaches for Assessing the Safety of Probiotic Bacteria. Food Control. 108:106872. doi:10.1016/j.foodcont.2019.106872.
   Web of Science ®Google Scholar
• Quigley EMM. 2017. Chapter 16 - Bifidobacterium longum. In: Floch MH, Ringel Y, Allan Walker W, eds. The Microbiota in Gastrointestinal Pathophysiology, Boston: Academic Press, p. 139–141.
   Google Scholar
• Roe AL, Boyte ME, Elkins C, Goldman VS, Heimbach J, Madden E, Oketch-Rabah H, Sanders ME, Sirois J, Smith A. 2022. Considerations for determining safety of probiotics: A USP perspective. Regul Toxicol Pharmacol. 136:105266. doi:10.1016/j.yrtph.2022.105266.
   PubMed Web of Science ®Google Scholar
• Sakata S, Kitahara M, Sakamoto M, Hayashi H, Fukuyama M, Benno Y. 2002. Unification of Bifidobacterium infantis and Bifidobacterium suis as Bifidobacterium longum. Int J Syst Evol Microbiol. 52(Pt 6):1945–1951. doi:10.1099/00207713-52-6-1945.
   PubMedGoogle Scholar
• Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, Fondén R, Saxelin M, Collins K, Mogensen G, et al. 1998. Demonstration of safety of probiotics–a review. Int J Food Microbiol. 44(1-2):93–106. doi:10.1016/s0168-1605(98)00128-7.
   PubMed Web of Science ®Google Scholar
• Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, Sarna S, Valtonen V, Järvinen A. 2002. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis. 35(10):1155–1160. doi:10.1086/342912.
   PubMed Web of Science ®Google Scholar
• Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, et al. 2010. Safety assessment of probiotics for human use. Gut Microbes. 1(3):164–185. doi:10.4161/gmic.1.3.12127.
   PubMed Web of Science ®Google Scholar
• Sarlin S, Tejesvi MV, Turunen J, Vänni P, Pokka T, Renko M, Tapiainen T. 2021. Impact of Streptococcus salivarius K12 on nasopharyngeal and saliva microbiome: a randomized controlled trial. Pediatr Infect Dis J. 40(5):394–402. doi:10.1097/inf.0000000000003016.
   PubMed Web of Science ®Google Scholar
• Schnadower D, Tarr PI, Casper TC, Gorelick MH, Dean JM, O’Connell KJ, Mahajan P, Levine AC, Bhatt SR, Roskind CG, et al. 2018. Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children. N Engl J Med. 379(21):2002–2014. doi:10.1056/nejmoa1802598.
   PubMed Web of Science ®Google Scholar
• Sommer MO, Dantas G, Church GM. 2009. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science. 325(5944):1128–1131. doi:10.1126/science.1176950.
   PubMed Web of Science ®Google Scholar
• Sudha RM. 2012a. Efficacy of Bacillus coagulans strain unique IS-2 in the treatment of patients with acute diarrhea. International Journal of Probiotics & Prebiotics: a Journal of Basic and Clinical Research on Gut Microbiota for Promotion of Human and Animal Health. 7(1):33–37. doi:10.3920/bm2017.0129.
   Google Scholar
• Sudha RM, Yelikar KA, Deshpande S. 2012b. Clinical study of Bacillus coagulans Unique IS-2 (ATCC PTA-11748) in the treatment of patients with bacterial vaginosis. Indian J Microbiol. 52(3):396–399. doi:10.1007/s12088-011-0233-z.
   PubMed Web of Science ®Google Scholar
• Sudha MR, Bhonagiri S, Kumar MA. 2013. Efficacy of Bacillus clausii strain UBBC-07 in the treatment of patients suffering from acute diarrhoea. Benef Microbes. 4(2):211–216. doi:10.3920/bm2012.0034.
   PubMed Web of Science ®Google Scholar
• Tapiovaara L, Lehtoranta L, Poussa T, Mäkivuokko H, Korpela R, Pitkäranta A. 2016. Absence of adverse events in healthy individuals using probiotics–analysis of six randomised studies by one study group. Benef Microbes. 7(2):161–169. doi:10.3920/bm2015.0096.
   PubMed Web of Science ®Google Scholar
• Tompkins TA, Hagen KE, Wallace TD, Fillion-Forté V. 2008. Safety evaluation of two bacterial strains used in Asian probiotic products. Can J Microbiol. 54(5):391–400. doi:10.1139/w08-022.
   PubMed Web of Science ®Google Scholar
• Toohey JC, Townsend JR, Johnson SB, Toy AM, Vantrease WC, Bender D, Crimi CC, Stowers KL, Ruiz MD, VanDusseldorp TA, et al. 2020. Effects of probiotic (Bacillus subtilis) supplementation during offseason resistance training in female division I athletes. J Strength Cond Res. 34(11):3173–3181. doi:10.1519/jsc.0000000000002675.
   PubMed Web of Science ®Google Scholar
• Townsend JR, Bender D, Vantrease WC, Sapp PA, Toy AM, Woods CA, Johnson KD. 2018. Effects of probiotic (Bacillus subtilis DE111) supplementation on immune function, hormonal status, and physical performance in division I baseball players. Sports (Basel). 6(3):70. doi:10.3390/sports6030070.
   PubMedGoogle Scholar
• Unique Biotech, Ltd. 2016. Self-affirmed GRAS Assessment for Bacillus clausii UBBC-07. Prepared by Soni and Associates, Inc. Date: September, 2016.
   Google Scholar
• Upadrasta A, Pitta S, Madempudi RS. 2016. Draft genome sequence of the spore-forming probiotic strain Bacillus coagulans Unique IS-2. Genome Announc. 4(2):1–2. doi:10.1128/genomeA.00225-16.
   Google Scholar
• USP. 2021. Guideline for the Admission of Dietary Supplement Ingredients to the USP–NF Monograph Development Process. Available at https://www.usp.org/sites/default/files/usp/document/get-involved/submission-guidelines/guideline-for-the-admission-of-dietary-supplement-ingredients.pdf. 2021. Accessed 14 November 2023.
   Google Scholar
• Wang B, Hylwka T, Smieja M, Surrette M, Bowdish DME, Loeb M. 2018. Probiotics to prevent respiratory infections in nursing homes: a pilot randomized controlled trial. J Am Geriatr Soc. 66(7):1346–1352. doi:10.1111/jgs.15396.
   PubMed Web of Science ®Google Scholar
• Weitzel MLJ, Vegge CS, Pane M, Goldman VS, Koshy B, Porsby CH, Burguière P, Schoeni JL. 2021. Improving and comparing probiotic plate count methods by analytical procedure lifecycle management. Front Microbiol. 12:693066. doi:10.3389/fmicb.2021.693066.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen J, Wu J, Chalson H, Merigan L, Mitchell A. 2013. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg Nutr. 2(3):142–147. doi:10.3978/j.issn.2304-3881.2013.06.05.
   PubMedGoogle Scholar
• Zheng J, Wittouck S, Salvetti E, Franz CMAP, Harris HMB, Mattarelli P, O’Toole PW, Pot B, Vandamme P, Walter J, et al. 2020. A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol. 70(4):2782–2858. doi:10.1099/ijsem.0.004107.
   PubMed Web of Science ®Google Scholar